InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,613.81
(
-0.22%
)
US TECH 100
18,829.80
(
-0.97%
)
Dow Jones
41,489.47
(
0.23%
)
Brent Oil
72.18
(
1.11%
)
Bitcoin
57,804.58
(
-2.32%
)
Post# of 253127
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 68
Posts 4505
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: dewophile post# 116140

Tuesday, 03/08/2011 6:04:46 PM

Tuesday, March 08, 2011 6:04:46 PM

Post# of 253127
First of all, some bioequivalence trials include actual patients. Second of all, we dismiss the notion of the requirement coming from FDA at this point because no one disclosed it. The buzz certainly could come from someone exploring efficacy/safety trial of biosimilar Copaxone for EU market because it is required over there.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up